Product
AlphaMedix
1 clinical trial
1 indication
Indication
Neuroendocrine TumorsClinical trial
A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in Subjects With Somatostatin Receptor Expressing Neuroendocrine TumorsStatus: Recruiting, Estimated PCD: 2026-10-01